Maravai Lifesciences Holdings Inc (MRVI) stock news · rev $185.7M
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
This MRVI news page leads with what Maravai Lifesciences Holdings Inc filed — not a scraped headline mill.
No cached 8-K sentence for MRVI yet. We will not pad this page with generic market recap.
Latest reported MRVI revenue for 2025-12-31 was $185.7M. Net income was -$130.8M. Revenue was down 28.3% from 2024-12-31 to 2025-12-31. MRVI currently screens at market cap $1.93B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MRVI stock page; for the tape open the quote page.
MRVI stock news FAQ
What are MRVI's latest revenue and net income?
Latest cached Maravai Lifesciences Holdings Inc (MRVI) revenue for Dec 31, 2025 was $185.7M. Net income was -$130.8M. Statements: https://lician.com/financials/mrvi
How did MRVI revenue change from the prior cached period?
Cached Maravai Lifesciences Holdings Inc (MRVI) revenue was down 28.3% from $259.2M (Dec 31, 2024) to $185.7M (Dec 31, 2025). Statements: https://lician.com/financials/mrvi
What is MRVI's market cap?
Maravai Lifesciences Holdings Inc (MRVI) market cap is $1.93B on the latest cached fundamentals snapshot.
What kind of company is MRVI?
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Where is MRVI stock news listed?
Cached stock news for Maravai Lifesciences Holdings Inc (MRVI) is listed at https://lician.com/news/mrvi. Filings: https://lician.com/sec/mrvi
Not investment advice.